HU171030B - Sposob poluchenija novykh oksim-ehfirnykh soedinenij s antidepressivnoj aktivnost'ju - Google Patents

Sposob poluchenija novykh oksim-ehfirnykh soedinenij s antidepressivnoj aktivnost'ju

Info

Publication number
HU171030B
HU171030B HU76PI00000513A HUPI000513A HU171030B HU 171030 B HU171030 B HU 171030B HU 76PI00000513 A HU76PI00000513 A HU 76PI00000513A HU PI000513 A HUPI000513 A HU PI000513A HU 171030 B HU171030 B HU 171030B
Authority
HU
Hungary
Prior art keywords
soedinij
poluchenija
oksim
novykh
ehfirnykh
Prior art date
Application number
HU76PI00000513A
Other languages
English (en)
Hungarian (hu)
Inventor
Hendricius B A Welle
Volkert Claassen
Original Assignee
Philips Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Philips Nv filed Critical Philips Nv
Publication of HU171030B publication Critical patent/HU171030B/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/32—Oximes
    • C07C251/50—Oximes having oxygen atoms of oxyimino groups bound to carbon atoms of substituted hydrocarbon radicals
    • C07C251/58—Oximes having oxygen atoms of oxyimino groups bound to carbon atoms of substituted hydrocarbon radicals of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C249/00—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C249/04—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton of oximes
    • C07C249/08—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton of oximes by reaction of hydroxylamines with carbonyl compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HU76PI00000513A 1975-03-20 1976-03-17 Sposob poluchenija novykh oksim-ehfirnykh soedinenij s antidepressivnoj aktivnost'ju HU171030B (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL7503310A NL7503310A (nl) 1975-03-20 1975-03-20 Verbindingen met antidepressieve werking.

Publications (1)

Publication Number Publication Date
HU171030B true HU171030B (hu) 1977-10-28

Family

ID=19823424

Family Applications (1)

Application Number Title Priority Date Filing Date
HU76PI00000513A HU171030B (hu) 1975-03-20 1976-03-17 Sposob poluchenija novykh oksim-ehfirnykh soedinenij s antidepressivnoj aktivnost'ju

Country Status (27)

Country Link
US (1) US4085225A (cg-RX-API-DMAC10.html)
JP (1) JPS6026776B2 (cg-RX-API-DMAC10.html)
AR (2) AR211011A1 (cg-RX-API-DMAC10.html)
AT (1) AT340895B (cg-RX-API-DMAC10.html)
AU (1) AU505358B2 (cg-RX-API-DMAC10.html)
BE (1) BE839744A (cg-RX-API-DMAC10.html)
CA (1) CA1076142A (cg-RX-API-DMAC10.html)
CH (4) CH626057A5 (cg-RX-API-DMAC10.html)
DD (1) DD128332A5 (cg-RX-API-DMAC10.html)
DE (1) DE2610886A1 (cg-RX-API-DMAC10.html)
DK (1) DK144942C (cg-RX-API-DMAC10.html)
ES (1) ES446192A1 (cg-RX-API-DMAC10.html)
FI (1) FI61875C (cg-RX-API-DMAC10.html)
FR (1) FR2304336A1 (cg-RX-API-DMAC10.html)
GB (1) GB1535226A (cg-RX-API-DMAC10.html)
GR (1) GR60052B (cg-RX-API-DMAC10.html)
HU (1) HU171030B (cg-RX-API-DMAC10.html)
IE (1) IE43768B1 (cg-RX-API-DMAC10.html)
IL (1) IL49238A (cg-RX-API-DMAC10.html)
IT (1) IT1063064B (cg-RX-API-DMAC10.html)
MX (1) MX9203723A (cg-RX-API-DMAC10.html)
NL (1) NL7503310A (cg-RX-API-DMAC10.html)
PL (3) PL100052B1 (cg-RX-API-DMAC10.html)
SE (1) SE410312B (cg-RX-API-DMAC10.html)
SU (3) SU635867A3 (cg-RX-API-DMAC10.html)
YU (1) YU39345B (cg-RX-API-DMAC10.html)
ZA (1) ZA761434B (cg-RX-API-DMAC10.html)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1110460B (it) * 1977-03-02 1985-12-23 Ciba Geigy Ag Prodotti che favoriscono la crescita delle piante e prodotti che proteggono le piante a base di eteri di ossime e di esteri di ossime loro preparazione e loro impiego
FR2639942B1 (fr) * 1988-12-02 1991-03-29 Sanofi Sa Ethers oximes de propenone, procede pour leur preparation et compositions pharmaceutiques les contenant
US5665756A (en) * 1994-08-03 1997-09-09 Hoechst Marion Roussel, Inc. Aminoalkyloximes useful in the treatment of depression and obsessive compulsive disorders
US6548084B2 (en) * 1995-07-20 2003-04-15 Smithkline Beecham Plc Controlled release compositions
EP0759299B1 (en) * 1995-08-16 2000-04-26 Eli Lilly And Company Potentiation of serotonin response
IN182588B (cg-RX-API-DMAC10.html) 1998-05-12 1999-05-08 Sun Pharmaceutical Ind Ltd
IE990406A1 (en) 1999-05-20 2000-12-27 Elan Corp Plc Multiparticulate controlled release selective serotonin reuptake inhibitor formulations.
IN186677B (cg-RX-API-DMAC10.html) 1999-11-12 2001-10-20 Sun Pharmaceutical Ind Ltd
WO2001078721A1 (en) * 2000-04-13 2001-10-25 Mayo Foundation For Medical Education And Research Aβ42 LOWERING AGENTS
US20080021085A1 (en) * 2000-04-13 2008-01-24 Mayo Foundation For Medical Education And Research Method of reducing abeta42 and treating diseases
US7256191B2 (en) * 2000-04-24 2007-08-14 Aryx Therapeutics Materials and methods for the treatment of depression
EP1276478A2 (en) * 2000-04-24 2003-01-22 ARYx Therapeutics (2-aminoethyl) oxime derivatives for the treatment of depression
NZ532033A (en) * 2001-10-12 2006-11-30 Azevan Pharmaceuticals Inc 2-(azetidin-2-on-1-yl)alkanedioic acid derivatives as vasopressin V1a receptor antagonists
EP1490090A4 (en) 2002-02-22 2006-09-20 New River Pharmaceuticals Inc SYSTEMS FOR DELIVERING ACTIVE AGENTS AND METHODS FOR PROTECTING AND DELIVERING ACTIVE AGENTS
EP1603548A4 (en) * 2003-02-05 2007-10-10 Myriad Genetics Inc METHOD AND COMPOSITION FOR THE TREATMENT OF NEURODEEGENERATIVE DISEASES
US20050042284A1 (en) * 2003-07-11 2005-02-24 Myriad Genetics, Incorporated Pharmaceutical methods, dosing regimes and dosage forms for the treatment of Alzheimer's disease
ATE449633T1 (de) 2003-09-12 2009-12-15 Pfizer Kombinationen aus alpha-2-delta liganden und serotonin / noradrenalin-wiederaufnahmehemmern
DE602004028150D1 (de) * 2003-11-26 2010-08-26 Pfizer Prod Inc Aminopyrazolderivate als gsk-3-inhibitoren
WO2005060968A1 (en) 2003-12-11 2005-07-07 Sepracor Inc. Combination of a sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression
WO2006001877A2 (en) * 2004-04-13 2006-01-05 Myriad Genetics, Inc. Combination treatment for neurodegenerative disorders comprising r-flurbiprofen
WO2005102366A2 (en) * 2004-04-19 2005-11-03 Philip Maxwell Satow Lithium combinations, and uses related thereto
AU2005241023A1 (en) * 2004-04-29 2005-11-17 Keystone Retaining Wall Systems, Inc. Veneers for walls, retaining walls and the like
WO2006020850A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
BRPI0514303A (pt) * 2004-08-11 2008-06-10 Myriad Genetics Inc composição farmacêutica e método para tratar distúrbios neurodegenerativos
WO2006020852A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
EP1868434A4 (en) 2005-03-22 2011-10-26 Azevan Pharmaceuticals Inc BETA-LACTAMYL ALKANIC ACIDS FOR THE TREATMENT OF PREMIERSTRUELLEN FAULTS
AU2006239920A1 (en) 2005-04-22 2006-11-02 Wyeth Dihydrobenzofuran derivatives and uses thereof
CN101203218A (zh) * 2005-04-22 2008-06-18 惠氏公司 苯并呋喃基链烷胺衍生物和其作为5－ht2c激动剂的用途
CN101203216A (zh) * 2005-04-22 2008-06-18 惠氏公司 二氢苯并呋喃衍生物及其用途
MX2007013179A (es) * 2005-04-22 2008-01-16 Wyeth Corp Formas cristalinas de clorhidrato de {[(2r)-7-(diclorofenil)-5- fluoro-2,3-dihidro-1-benzofurano-2-il]metil}amina.
SG163588A1 (en) 2005-07-08 2010-08-30 Braincells Inc Methods for identifying agents and conditions that modulate neurogenesis
US20070015832A1 (en) * 2005-07-14 2007-01-18 Myriad Genetics, Incorporated Methods of treating overactive bladder and urinary incontinence
PL1910346T3 (pl) * 2005-07-19 2019-09-30 Azevan Pharmaceuticals, Inc. Beta-laktamowy antagonista wazopresyny fenyloalaniny, cysteiny i seryny
EP1909777A2 (en) * 2005-07-22 2008-04-16 Myriad Genetics, Inc. High drug load formulations and dosage forms
JP2009512711A (ja) 2005-10-21 2009-03-26 ブレインセルス，インコーポレイティド Ｐｄｅ阻害による神経新生の調節
JP2009513672A (ja) 2005-10-31 2009-04-02 ブレインセルス，インコーポレイティド 神経発生のｇａｂａ受容体媒介調節
FR2912057B1 (fr) * 2007-02-07 2009-04-17 Sanofi Aventis Sa Composition pharmaceutique contenant en association le saredutant et un inhibiteur selectif de la recapture de la serotonine ou un inhibiteur de la recapture de la serotonine/norepinephrine
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
RU2008135326A (ru) * 2006-03-24 2010-04-27 Вайет (Us) Терапевтические композиции для лечения депрессии
JP4615470B2 (ja) * 2006-03-29 2011-01-19 卓郎 簑和田 大脳の認知力を用いた疾患治療・予防の方法および医薬
WO2007134077A2 (en) 2006-05-09 2007-11-22 Braincells, Inc. 5 ht receptor mediated neurogenesis
AU2007249399A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
US7858611B2 (en) * 2006-05-09 2010-12-28 Braincells Inc. Neurogenesis by modulating angiotensin
US20080033045A1 (en) * 2006-07-07 2008-02-07 Myriad Genetics, Incorporated Treatment of psychiatric disorders
TW200817003A (en) * 2006-07-31 2008-04-16 Sanofi Aventis Pharmaceutical composition comprising, in combination, saredutant and a selective serotonin peuptake inhibitor or a serotonin/norepinephrine reuptake inhibitor
MX2009002496A (es) 2006-09-08 2009-07-10 Braincells Inc Combinaciones que contienen un derivado de 4-acilaminopiridina.
WO2008034032A2 (en) * 2006-09-14 2008-03-20 Azevan Pharmaceuticals, Inc. Beta-lactam cannabinoid receptor modulators
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
WO2008083204A2 (en) * 2006-12-28 2008-07-10 Braincells, Inc. Modulation of neurogenesis by melatoninergic ligands
CA2675132A1 (en) * 2007-01-11 2008-07-17 Braincells, Inc. Modulation of neurogenesis with use of modafinil
WO2009128058A1 (en) 2008-04-18 2009-10-22 UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN et al Psycho-pharmaceuticals
WO2010021681A2 (en) * 2008-08-18 2010-02-25 Combinatorx (Singapore) Pte. Ltd. Compositions and methods for treatment of viral diseases
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
PT2491038T (pt) 2009-10-23 2016-07-14 Janssen Pharmaceutica Nv Octahidropirrolo[3,4-c]pirrolos disubstituídos como modeladores de recetores de orexina
WO2011071995A2 (en) 2009-12-08 2011-06-16 Case Western Reserve University Compounds and methods of treating ocular disorders
WO2012003436A1 (en) 2010-07-01 2012-01-05 Azevan Pharmaceuticals, Inc. Methods for treating post traumatic stress disorder
WO2012123922A1 (en) 2011-03-17 2012-09-20 Lupin Limited Controlled release pharmaceutical compositions of selective serotonin reuptake inhibitor
KR101427221B1 (ko) * 2012-08-29 2014-08-13 주식회사 에스텍파마 플루복사민 자유 염기의 정제방법 및 이를 이용한 고순도 플루복사민 말레이트의 제조방법
WO2014178064A2 (en) * 2013-04-03 2014-11-06 Zcl Chemicals Limited "an improved process for the preparation of fluvoxamine maleate"
PL3104847T3 (pl) 2014-02-07 2021-07-05 Támogatott Kutatócsoportok Irodája Nowe zastosowanie związków agonistycznych receptora sigma-1
MX2021005502A (es) 2014-03-28 2023-01-16 Azevan Pharmaceuticals Inc Composiciones y metodos para tratar enfermedades neurodegenerativas.
KR102559922B1 (ko) 2016-03-10 2023-07-25 얀센 파마슈티카 엔.브이. 오렉신-2 수용체 길항제를 사용한 우울증의 치료 방법
MA46898A (fr) 2016-11-24 2019-10-02 Sigmadrugs Kutato Korlatolt Feleloessegue Tarsasag Compositions pour la conservation d'organes
BR112020005107A2 (pt) 2017-09-15 2020-11-03 Azevan Pharmaceuticals, Inc. composições e métodos para o tratamento de lesão cerebral
KR20220049526A (ko) 2019-07-19 2022-04-21 바이오엑셀 테라퓨틱스 인코포레이티드 비-진정성 덱스메데토미딘 치료 양생법
US11806334B1 (en) 2023-01-12 2023-11-07 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3692835A (en) * 1967-04-05 1972-09-19 Jan Van Dijk Pharmacologically active amino-ethyl oximes

Also Published As

Publication number Publication date
BE839744A (fr) 1976-09-20
AU1214776A (en) 1977-09-22
CH629761A5 (de) 1982-05-14
AR211011A1 (es) 1977-10-14
CH629477A5 (de) 1982-04-30
SU620206A3 (ru) 1978-08-15
DK144942B (da) 1982-07-12
IT1063064B (it) 1985-02-11
FR2304336B1 (cg-RX-API-DMAC10.html) 1979-09-28
ZA761434B (en) 1977-10-26
DD128332A5 (de) 1977-11-09
CH629184A5 (de) 1982-04-15
DE2610886A1 (de) 1976-10-07
SU635867A3 (ru) 1978-11-30
AU505358B2 (en) 1979-11-15
IL49238A (en) 1978-08-31
PL100052B1 (pl) 1978-08-31
GR60052B (en) 1978-04-04
GB1535226A (en) 1978-12-13
IE43768L (en) 1976-09-20
SE7603341L (sv) 1976-09-21
PL100614B1 (pl) 1978-10-31
DE2610886C2 (cg-RX-API-DMAC10.html) 1987-09-24
CA1076142A (en) 1980-04-22
FI61875C (fi) 1982-10-11
JPS51125345A (en) 1976-11-01
FI760699A7 (cg-RX-API-DMAC10.html) 1976-09-21
DK144942C (da) 1982-12-06
ATA195476A (de) 1977-05-15
NL7503310A (nl) 1976-09-22
IE43768B1 (en) 1981-05-20
ES446192A1 (es) 1977-10-01
YU39345B (en) 1984-10-31
IL49238A0 (en) 1976-05-31
SU645559A3 (ru) 1979-01-30
AT340895B (de) 1978-01-10
JPS6026776B2 (ja) 1985-06-25
US4085225A (en) 1978-04-18
MX9203723A (es) 1992-07-01
FR2304336A1 (fr) 1976-10-15
CH626057A5 (cg-RX-API-DMAC10.html) 1981-10-30
SE410312B (sv) 1979-10-08
PL101951B1 (pl) 1979-02-28
DK115976A (da) 1976-09-21
FI61875B (fi) 1982-06-30
AR211153A1 (es) 1977-10-31
YU71476A (en) 1982-10-31

Similar Documents

Publication Publication Date Title
HU171030B (hu) Sposob poluchenija novykh oksim-ehfirnykh soedinenij s antidepressivnoj aktivnost'ju
HU174805B (hu) Sposob poluchenija katalizatorov dlja polimerizacii al'fa-olefinov
HU175109B (hu) Sposob poluchenija novykh benzgidril-sul'finilovykh proizvodnykh
FR2312908A1 (fr) Casque d'ecoute
HU171717B (hu) Sposob poluchenija slozhnykh alkil'nykh ehfirov 1,4-digidropiridin-karbonovoj kisloty i lechebnykh preparatov soderzhahhikh takie soedinenija
HU175142B (hu) Sposob poluchenija kompoziciju inzulina s dlinnojj aktivnost'ju i s malenkojj antigennojj aktivnost'ju
HU172533B (hu) Sposob poluchenija tvjordykh rastvorov alkaloidov sporyn'i i ikh proizvodnykh
FR2330926A1 (fr) Elements d'etancheite
FR2302812A1 (fr) Machine d'oxycoupage
FR2308454A1 (fr) Machine d'oxycoupage
HU175339B (hu) Sposob poluchenija farmacevticheski priemlemykh dibaznykh solejj beta-laktam-antibiotiki mm 17880
FR2318135A1 (fr) Oxychloruration de l'ethylene
FR2302232A1 (fr) Stoppeur d'aussiere
FR2297628A1 (fr) 2,3-dihydroergolines
FR2314732A1 (fr) Solution d'iodophore
JPS51100070A (ja) 1*22benzoisochiazooruruinoseiho
SE7608417L (sv) 2-klor-n-isopropyl-2',3'-dimetylacetanilid
HU175490B (hu) Ustrojstvo vybora naprjazhenija dlja grupirovki otopitel'nykh soprotivlenij u zheleznodorozhnykh vagonov mezhdunarodnogo soobhhenija
HU172482B (hu) Sposob poluchenija sul'famoil-benzojnykh kislot
BE844697A (fr) Ar-octahalodiphenyl-ether-4,4'-dimethanol
HU174428B (hu) Ustanovka dlja nasyhhenija zhidkost'ju dereva, derevjannykh i drugikh poristykh izdelij
JPS51109263A (ja) Kinzokusutoritsupuno 2 jokirisuritsutoseihinno makitorihoho
HU175268B (hu) Sposob poluchenija smoly-kleja mocheviny-formaldegida s bol'shojj effektivnost'ju dlja kholodnojj klejjki
HU172088B (hu) Sposob ochistki hhelevykh prokhodov raspredelitel'nykh i sbornykh trub ionnoobmennogo stolbika
HU173573B (hu) Sposob poluchenija novykh proizvodnykh 1,8-naftridina

Legal Events

Date Code Title Description
HU90 Patent valid on 900628